Go to content
UR Home

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

Tak, P. P., Rigby, W. F., Rubbert-Roth, A. and Fleck, Martin (2011) Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Annals of the Rheumatic Diseases 70, pp. 39-46.

[img]
Preview
License: Allianz- bzw. Nationallizenz
PDF - Published Version
Download (262kB)
Date of publication of this fulltext: 08 Aug 2017 08:26

at publisher (via DOI)


Abstract

Objectives: Rituximab is an effective treatment in patients with established rheumatoid arthritis (RA). The objective of the IMAGE study was to determine the efficacy of rituximab in the prevention of joint damage and its safety in combination with methotrexate (MTX) in patients initiating treatment with MTX. Methods: In this double-blind randomised controlled phase III study, 755 MTX-naïve ...

plus


Export bibliographical data



Item type:Article
Date:2011
Institutions:Medicine > Lehrstuhl für Innere Medizin I
Identification Number:
ValueType
10.1136/ard.2010.137703DOI
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Partially
Item ID:36083
Owner only: item control page

Downloads

Downloads per month over past year

  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons